Pfizer Inc annual net income for fiscal TTM was $7.5 billion, a decrease of 3.6% from $7.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $7.5B | $7.8B | $8.0B | $2.1B | $31.4B | $22.1B | $9.2B | $16.3B | $11.2B | $21.3B | $7.2B | $7.0B | $9.1B | $11.6B | $9.8B | $8.7B | $8.3B | $8.6B | $8.0B | $8.2B | $11.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $2.7B | ($1.6B) | $3.5B | $2.9B | $3.0B | $403M | $4.5B | $24M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PFE metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All PFE financial statements → Interactive PFE charts →
About TickerBase · Data methodology & sources